Cue Health Company Overview
Cue Health
About Cue Health
Cue Health (NASDAQ:HLTH) specializes in healthcare technology, focusing on the development of innovative diagnostic solutions for a wide range of medical conditions and diseases. Its offerings aim at empowering individuals and healthcare professionals with accessible, accurate, and rapid testing capabilities. The company's notable projects include the development of portable, point-of-care diagnostic tests for COVID-19, which gained significant attention during the pandemic. Cue Health's objectives are centered around expanding its product lineup, enhancing the integration of its technology with healthcare systems, and making diagnostic testing more convenient and accessible worldwide.
What is Cue Health known for?
Snapshot
2010
Year founded
726
Employees
California, United States
Head office
Loading Map...
Operations
All Locations
United States
Products and/or services of Cue Health
- Cue COVID-19 Test - A rapid, portable molecular test for the detection of the SARS-CoV-2 virus.
- Cue Reader - A compact device that utilizes molecular technology for diagnostic testing at point-of-care.
- Cue Virtual Care Platform - A digital platform supporting virtual consultations and integration with Cue's diagnostic tests.
- Cue Health Monitoring System - A comprehensive solution for tracking vital health indicators and test results over time.
- Cue Flu Test - A highly sensitive, rapid diagnostic test designed to detect influenza A and B viruses.
- Cue Dashboard - An analytical tool for health professionals to monitor population health trends and manage outbreaks.
Cue Health executive team
- Mr. Clint SeverCo-Founder & CEO
- Mr. Randall E. PollardChief Accounting Officer, Controller & Principal Financial Officer
- Ms. Allison F. BlackwellChief Human Resources Officer
- Mr. Christopher K. AcharChief Business Officer & Director
- Dr. David Tsay M.D., Ph.D.Chief Medical Officer